Reta Glp3

Description:

Retatrutide is a synthetic peptide under clinical investigation for its remarkable effects on metabolic function, fat oxidation, and energy regulation. It acts as a triple receptor agonist, uniquely targeting the GLP-1, GIP, and Glucagon receptors — a combination that mimics and enhances natural metabolic hormones.

Researchers are studying Retatrutide for its potential role in:

• Appetite regulation

• Body weight reduction

• Fat metabolism

• Insulin sensitivity

• Energy homeostasis

This triple-action mechanism makes Retatrutide one of the most promising compounds in the next generation of metabolic peptide research.

🧬 Mechanism of Action:

• GLP-1 receptor activation: Promotes satiety and delays gastric emptying

• GIP receptor activation: Enhances insulin secretion and glucose control

• Glucagon receptor activation: Stimulates lipolysis and energy expenditure

Together, these pathways may contribute to body fat reduction, improved glucose metabolism, and enhanced metabolic flexibility — all of which are crucial in obesity, diabetes, and longevity research.

⚗️ Available Research Strengths:

• 5 mg

• 10 mg

• 20 mg
  (Custom vial sizes available upon request)

📌 Formulation & Storage:

• Lyophilized powder

• Store dry at ≤–20°C

• Reconstitute with bacteriostatic water for solution stability

• For research use only. Not for human or veterinary use.